PLUT Overview

IPO and Additional Shares: Plutus Financial Group Limited announced that R.F. Lafferty & Co., Inc. exercised an over-allotment option, purchasing an additional 150,000 shares at $4.00 each, raising a total of $9 million from its IPO.

Company Overview: Plutus Financial Group operates through two subsidiaries, providing a range of financial services including securities brokerage, wealth management, and investment advisory services in Hong Kong.

Recent IPOs: Several companies, including Webus International, Luda Technology, and Basel Medical, made their public debuts this week with varying opening prices, while others like Anbio Biotechnology and Stak also saw notable performances post-IPO.

Upcoming IPOs: Companies such as Everbright Digital, DailyPay, and Odyssey Therapeutics are preparing for potential IPOs, with expectations of significant valuations and market interest in the near future.

Sionna Therapeutics IPO Performance: Sionna Therapeutics debuted on February 7 with an upsized public offering, opening at $25.00 after pricing shares at $18.00, reflecting a strong interest in its cystic fibrosis treatment pipeline.

Upcoming IPOs and Market Activity: Titan America had a modest opening at $16.20, while other companies like Karman Holdings and DailyPay are preparing for potential IPOs, indicating ongoing market activity in the biotech and financial services sectors.

Initial Public Offering Announcement: Plutus Financial Group Limited successfully closed its initial public offering of 2,100,000 ordinary shares at $4 per share, raising a total of $8.4 million, with shares now trading on Nasdaq under the ticker "PLUT".

Company Overview: The company operates through two subsidiaries, providing a range of financial services including securities brokerage, margin financing, and wealth management, while also emphasizing the importance of reviewing their final prospectus before investing.